Literature DB >> 11927592

A highly effective dominant negative alpha s construct containing mutations that affect distinct functions inhibits multiple Gs-coupled receptor signaling pathways.

Catherine H Berlot1.   

Abstract

To investigate the subcellular organization of receptor-G protein signaling pathways, a robust dominant negative alpha(s) mutant containing substitutions that alter distinct functions was produced and tested for its effects on G(s)-coupled receptor activity in HEK-293 cells. Mutations in the alpha3beta5 loop region, which increase receptor affinity, decrease receptor-mediated activation, and impair activation of adenylyl cyclase, were combined with G226A, which increases affinity for betagamma, and A366S, which decreases affinity for GDP. This triple alpha(s) mutant can inhibit signaling to G(s) from the luteinizing hormone receptor by 97% and from the calcitonin receptor by 100%. In addition, this alpha(s) mutant blocks all signaling from the calcitonin receptor to G(q). These results lead to two conclusions about receptor-G protein signaling. First, individual receptors have access to multiple types of G proteins in HEK-293 cell membranes. Second, different G protein alpha subunits can compete with each other for binding to the same receptor. This dominant negative alpha(s) construct will be useful for determining interrelationships among distinct receptor-G protein interactions in a wide variety of cells and tissues.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11927592     DOI: 10.1074/jbc.M201330200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  Prolonged signaling at the parathyroid hormone receptor by peptide ligands targeted to a specific receptor conformation.

Authors:  Makoto Okazaki; Sebastien Ferrandon; Jean-Pierre Vilardaga; Mary L Bouxsein; John T Potts; Thomas J Gardella
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-22       Impact factor: 11.205

2.  A dominant-negative Galpha mutant that traps a stable rhodopsin-Galpha-GTP-betagamma complex.

Authors:  Sekar Ramachandran; Richard A Cerione
Journal:  J Biol Chem       Date:  2011-02-01       Impact factor: 5.157

Review 3.  Non-canonical signaling of the PTH receptor.

Authors:  Jean-Pierre Vilardaga; Thomas J Gardella; Vanessa L Wehbi; Timothy N Feinstein
Journal:  Trends Pharmacol Sci       Date:  2012-06-16       Impact factor: 14.819

4.  Phase-plate cryo-EM structure of a biased agonist-bound human GLP-1 receptor-Gs complex.

Authors:  Yi-Lynn Liang; Maryam Khoshouei; Alisa Glukhova; Sebastian G B Furness; Peishen Zhao; Lachlan Clydesdale; Cassandra Koole; Tin T Truong; David M Thal; Saifei Lei; Mazdak Radjainia; Radostin Danev; Wolfgang Baumeister; Ming-Wei Wang; Laurence J Miller; Arthur Christopoulos; Patrick M Sexton; Denise Wootten
Journal:  Nature       Date:  2018-02-21       Impact factor: 49.962

5.  Stimulation of proglucagon gene expression by human GPR119 in enteroendocrine L-cell line GLUTag.

Authors:  Oleg G Chepurny; Daniela Bertinetti; Mandy Diskar; Colin A Leech; Parisa Afshari; Tamara Tsalkova; Xiaodong Cheng; Frank Schwede; Hans-G Genieser; Friedrich W Herberg; George G Holz
Journal:  Mol Endocrinol       Date:  2013-06-24

Review 6.  Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm.

Authors:  Jean-Pierre Vilardaga; Guillermo Romero; Peter A Friedman; Thomas J Gardella
Journal:  Cell Mol Life Sci       Date:  2010-08-12       Impact factor: 9.261

7.  Altered selectivity of parathyroid hormone (PTH) and PTH-related protein (PTHrP) for distinct conformations of the PTH/PTHrP receptor.

Authors:  Thomas Dean; Jean-Pierre Vilardaga; John T Potts; Thomas J Gardella
Journal:  Mol Endocrinol       Date:  2007-09-13

8.  Sustained cyclic AMP production by parathyroid hormone receptor endocytosis.

Authors:  Sébastien Ferrandon; Timothy N Feinstein; Marian Castro; Bin Wang; Richard Bouley; John T Potts; Thomas J Gardella; Jean-Pierre Vilardaga
Journal:  Nat Chem Biol       Date:  2009-08-23       Impact factor: 15.040

9.  A novel cyclic adenosine monophosphate responsive luciferase reporter incorporating a nonpalindromic cyclic adenosine monophosphate response element provides optimal performance for use in G protein coupled receptor drug discovery efforts.

Authors:  Oleg G Chepurny; George G Holz
Journal:  J Biomol Screen       Date:  2007-05-16

10.  The same mutation in Gsalpha and transducin alpha reveals behavioral differences between these highly homologous G protein alpha-subunits.

Authors:  Adolfo R Zurita; Lutz Birnbaumer
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.